Search results for "phage"

showing 10 items of 1573 documents

Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and b…

2004

The increasing use of endoscopic resection for curative treatment of early oesophageal cancers requires accurate staging before therapy. In a prospective blinded trial, we compared staging of early oesophageal carcinoma using high resolution endoscopy (HR-E) with staging using high resolution endosonography (HR-EUS).A total of 100 patients (89 men, 11 women; mean age 63.9 (10.8) years (range 31-91)) with a suspicion of early oesophageal adenocarcinoma (n = 81) or squamous cell carcinoma (n = 19) were enrolled in the study. After endoscopic staging with high resolution video endoscopy by two experienced endoscopists, HR-EUS was performed by an experienced endosonographer who was blinded to t…

AdultMalemedicine.medical_specialtyEsophageal NeoplasmsHigh resolutionAdenocarcinomaEndosonographySubmucosamedicineCarcinomaHumansSingle-Blind MethodProspective StudiesEsophagusProspective cohort studyAgedNeoplasm StagingAged 80 and overmedicine.diagnostic_testbusiness.industryGastroenterologyReproducibility of ResultsCancerMiddle Agedmedicine.diseasedigestive system diseasesSurgeryEndoscopyOesophagusmedicine.anatomical_structureCarcinoma Squamous CellAdenocarcinomaFemaleEsophagoscopyRadiologybusinessGut
researchProduct

Biomonitoring of Multiple Mycotoxins in Urine by GC–MS/MS: A Pilot Study on Patients with Esophageal Cancer in Golestan Province, Northeastern Iran

2021

A pilot study to investigate the occurrence of 10 mycotoxins (deoxynivalenol, DON

AdultMalemedicine.medical_specialtyEsophageal NeoplasmsLiquid Phase MicroextractionHealth Toxicology and Mutagenesislcsh:MedicinePilot ProjectsUrineIranToxicologymedicine.disease_cause01 natural sciencesGastroenterologyDiacetoxyscirpenolGas Chromatography-Mass SpectrometryArticlechemistry.chemical_compoundYoung Adult0404 agricultural biotechnologyInternal medicinemycotoxinsmedicineHumansZearalanoneesophageal cancerMycotoxinZearalenoneAgedAged 80 and overCreatininebusiness.industryToxin010401 analytical chemistrylcsh:RGC–MS/MSurine biomarkers04 agricultural and veterinary sciencesMiddle Aged040401 food science0104 chemical scienceschemistryCase-Control StudiesBody BurdenFemaleGas chromatography–mass spectrometrybusinessBiological MonitoringToxins
researchProduct

Survival of stomach and esophagus cancer patients in Germany in the early 21st century

2012

Esophagus and stomach cancers are associated with poor prognosis. But most published population-based cancer survival estimates for stomach and esophagus cancer refer to survival experience of patients diagnosed in the 1990s or earlier years. The aim of this study was to provide up-to-date survival estimates and trends for patients with stomach and esophagus cancer in Germany.Our analysis is based on data from 11 population-based cancer registries, covering 33 million inhabitants. Patients diagnosed with stomach and esophagus cancer in 1997-2006 were included. Period analysis was used to derive five-year relative survival estimates and trends by age, sex, cancer subsite, and stage for the t…

AdultMalemedicine.medical_specialtyEsophageal NeoplasmsPopulationAdenocarcinomaGastroenterologyStomach NeoplasmsGermanyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRegistriesSex DistributionEsophagusStage (cooking)educationSurvival analysisAgededucation.field_of_studyRelative survivalbusiness.industryStomachCancerHematologyGeneral MedicineMiddle Agedmedicine.diseaseSurvival AnalysisUnited StatesSurvival Ratemedicine.anatomical_structureOncologyPeriod AnalysisFemaleEsophagogastric JunctionbusinessSEER ProgramActa Oncologica
researchProduct

Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center bi…

2011

Abstract Background Cetuximab plus irinotecan/folinic acid/5-fluorouracil (5-FU) (IF) was evaluated as first-line treatment of patients with advanced gastric cancer and gastroesophageal junction tumors. Preplanned analyses of the influence of tumor biomarkers on treatment outcome were carried out. Patients and methods Patients received weekly cetuximab (400 mg/m2 on day 1, subsequently 250 mg/m2) plus irinotecan (80 mg/m2) and a 24-hour continuous infusion of folinic acid (200 mg/m2) and 5-FU (1500 mg/m2) on days 1, 8, 15, 22, 29 and 36 of a 50-day cycle, until progressive disease (PD). Results The most common grade 3/4 toxic effects in 49 patients were diarrhea (15%) and skin toxic effects…

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.drug_classMedizinLeucovorinPhases of clinical researchCetuximabAntibodies Monoclonal HumanizedIrinotecanAntimetaboliteGastroenterologyFolinic acidStomach NeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansProgression-free survivalAgedCetuximabbusiness.industryAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseSurgeryIrinotecanTreatment OutcomeOncologyFluorouracilCamptothecinFemaleFluorouracilbusinessProgressive diseasemedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Prospective Evaluation of Positron Emission Tomography in the Preoperative Staging of Esophageal Carcinoma

2004

Hypothesis Positron emission tomography (PET) is a useful tool in the selection of patients with esophageal cancer who may not benefit from esophageal resection. Design Case series. Setting Tertiary care hospital. Patients Eighty-one patients with newly diagnosed esophageal cancer who underwent PET and computer tomography (CT) of the chest and abdomen (and of the neck in 45 patients) within 45 days were included. Main Outcome Measures We calculated the sensitivity and specificity in detecting metastatic sites on the basis of 31 histologically verified lesions. In addition to results obtained on CT, the information provided by PET was evaluated with a view to the choice of management strateg…

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentAdenocarcinomaSensitivity and SpecificityPreoperative carePreoperative CaremedicineCarcinomaHumansProspective StudiesAgedNeoplasm Stagingmedicine.diagnostic_testEsophageal diseasebusiness.industryMiddle AgedEsophageal cancermedicine.diseaseSurgerymedicine.anatomical_structureEsophagectomyPositron emission tomographyPositron-Emission TomographyCarcinoma Squamous CellAbdomenFemaleSurgeryTomographyRadiologyTomography X-Ray ComputedbusinessArchives of Surgery
researchProduct

Carcinoma of the hypopharynx and the cervical oesophagus: a surgical challenge.

1999

To report our results after reconstruction of the upper digestive tract for locally advanced carcinoma of the hypopharynx and cervical oesophagus.Open study.Teaching University hospital, Germany.Of the 517 patients who presented with carcinoma of the oesophagus between September 1985 and March 1997, 16 had a locally advanced tumour of the hypopharynx and 25 of the cervical oesophagus.Free jejunal grafts were used after circular resection in all patients with carcinoma of the hypopharynx, and for the 3 with oesophageal carcinoma in whom we obtained adequate resection margins. In the remainder stomach was used in 21 and colon in 1.Morbidity and mortality.After jejunal grafting 1 patient died …

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentAnastomosisAdenocarcinomaEsophagusPostoperative ComplicationsHypopharyngeal Neoplasmotorhinolaryngologic diseasesmedicineCarcinomaHumansHospital MortalityEsophagusSurvival rateNeoplasm StagingHypopharyngeal Neoplasmsbusiness.industryStomachdigestive oral and skin physiologyMiddle Agedmedicine.diseaseSurgeryEsophagectomySurvival RateHypopharynxmedicine.anatomical_structureJejunumEsophagectomyCarcinoma Squamous CellAdenocarcinomaSurgeryFemalebusinessThe European journal of surgery = Acta chirurgica
researchProduct

Recurrent laryngeal nerve paralysis (RLNP) following esophagectomy for carcinoma.

2005

Abstract Background The aim of this study was to report the frequency of post-operative recurrent laryngeal nerve paralysis (RLNP) following resection for esophageal carcinoma. Patients and methods Four hundred and four patients were studied. Diagnosis of post-operative RLNP was performed by indirect laryngoscopy. Tumour characteristics, surgical approach and perioperative morbidity and mortality following esophageal resection were recorded. Results Sixty patients were diagnosed with post-operative RLNP, of whom 47 had a unilateral and 16 a bilateral lesion. RLNP was more frequently diagnosed after transhiatal resection with cervical esophagogastrostomy as compared to abdomino-thoracic rese…

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentLaryngoscopyRecurrent laryngeal nerveCarcinomaParalysisMedicineHumansAgedRetrospective Studiesmedicine.diagnostic_testLaryngoscopybusiness.industryCarcinomaRetrospective cohort studyGeneral MedicinePerioperativePneumoniaEsophageal cancerMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryEsophagectomyOncologyEsophagectomyRecurrent Laryngeal Nerve InjuriesSurgeryFemalemedicine.symptombusinessVocal Cord ParalysisEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct

Influence of splenectomy on perioperative morbidity and long-term survival after esophagectomy in patients with esophageal carcinoma

2005

The aim of this study was to determine the influence of splenectomy on perioperative morbidity and mortality, as well as on the long-term survival after esophageal resection for carcinoma of the esophagus. From September 1985 to July 2003, 404 patients underwent surgery for esophageal carcinoma in our institution. Splenectomy was performed in 34 (8.4%) patients. Perioperative morbidity and long-term survival were compared in patients with and without concomitant splenectomy. Splenectomy was associated with an increase in intraoperative blood loss and the need for transfusions of blood preserves (P0.0001). However, there were no significant differences in pulmonary, general, or surgical comp…

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentSplenectomyAdenocarcinomaIntensive careCarcinomamedicineHumansEsophagusSurvival rateAgedAged 80 and overbusiness.industryGastroenterologyGeneral MedicinePerioperativeMiddle Agedmedicine.diseaseSurvival AnalysisSurgerymedicine.anatomical_structureEsophagectomyCarcinoma Squamous CellSplenectomyAdenocarcinomaFemalebusinessDiseases of the Esophagus
researchProduct

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

2021

BackgroundNo adjuvant treatment has been established for patients who remain at high risk for recurrence after neoadjuvant chemoradiotherapy and surgery for esophageal or gastroesophageal junction cancer. MethodsWe conducted CheckMate 577, a global, randomized, double-blind, placebo-controlled phase 3 trial to evaluate a checkpoint inhibitor as adjuvant therapy in patients with esophageal or gastroesophageal junction cancer. Adults with resected (R0) stage II or III esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy and had residual pathological disease were randomly assigned in a 2:1 ratio to receive nivolumab (at a dose of 240 mg every 2 weeks fo…

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatment[SDV.CAN]Life Sciences [q-bio]/CancerKaplan-Meier EstimateAdenocarcinoma030204 cardiovascular system & hematologyGastroenterologyB7-H1 AntigenDisease-Free Survival03 medical and health sciences0302 clinical medicineDouble-Blind MethodStomach NeoplasmsInternal medicineMedicine and Health SciencesmedicineCarcinomaHumans030212 general & internal medicineEsophagusImmune Checkpoint InhibitorsNeoadjuvant therapyAgedAged 80 and overChemotherapybusiness.industryCancerChemoradiotherapy AdjuvantGeneral MedicineMiddle Agedmedicine.diseaseNeoadjuvant TherapyIntention to Treat Analysis3. Good healthNivolumabmedicine.anatomical_structureChemotherapy AdjuvantCarcinoma Squamous CellFemaleEsophagogastric JunctionNivolumabbusinessAdjuvantChemoradiotherapyNew England Journal of Medicine
researchProduct

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease.

2009

Introduction: Functional dyspepsia and non-erosive reflux disease (NERD) are prevalent gastrointestinal conditions with accumulating evidence regarding an overlap between the two. Still, patients with NERD represent a very heterogeneous group and limited data on dyspeptic symptoms in various subgroups of NERD are available. Aim: To evaluate the prevalence of dyspeptic symptoms in patients with NERD subclassified by using 24 h impedance-pH monitoring (MII-pH). Methods: Patients with typical reflux symptoms and normal endoscopy underwent impedance-pH monitoring off proton pump inhibitor treatment. Oesophageal acid exposure time (AET), type of acid and non-acid reflux episodes, and symptom ass…

AdultMalemedicine.medical_specialtyEsophageal pH MonitoringAdolescentNerdmedicine.drug_classProton-pump inhibitorGastroenterologyBody Mass IndexDiagnosis DifferentialYoung AdultEsophagusSex FactorsHeartburnInternal medicinemedicineElectric ImpedanceHumansNERD FD FH SAP1506EsophagusDyspepsiaAgedAnalysis of Variancemedicine.diagnostic_testbusiness.industryEsophageal diseaseStomachdigestive oral and skin physiologyStomachGastroenterologyRefluxHeartburnMiddle Agedmedicine.diseasedigestive system diseasesOesophagusmedicine.anatomical_structureGastroesophageal RefluxFemaleEsophagoscopymedicine.symptombusinessEsophageal pH monitoring
researchProduct